Abstracts

SUCCESSFUL PERITRANSPLANT SOFOSBUVIR-BASED DAA THERAPY IN HIV/HCV-COINFECTED SUBJECTS

Direct acting antiviral (DAA) therapy has transformed the management of human Immunodeficiency virus (HIV) and hepatitis C (HCV) coinfected patients with advanced liver disease. STOP-Coinfection was a multi-center, prospective and retrospective, open-label study using sofosbuvir-based DAA therapy to treat HIV/HCV coinfected participants pre- or post-liver transplant (LT). The study included adults living with HIV and…

LIVER STIFFNESS–BASED STRATEGIES FOR VARICEAL BLEEDING PREDICTION AFTER HCV CURE

Liver stiffness (LS)-based strategies identify patients with low risk of developing esophageal variceal bleeding (VB) episodes, in whom unnecessary upper esophagogastroduodenoscopy (UGE) screening can be safely avoided, in the setting of HCV active infection. However, data on the accuracy of the criteria predicting this outcome in HCV-infected patients with cirrhosis, with or without HIV-coinfection, after…

MULTIPLE HIGH-RISK AND NONVACCINE HPV TYPES IN HIV+ UGANDAN WOMEN ON LONG-TERM ART

Cervical cancer is a leading cause of cancer mortality in sub-Saharan Africa, with increased risk among women living with HIV (WLWH). Improved understanding of the prevalence and distribution of high-risk human papillomavirus (hrHPV) and measures of immune dysfunction among WLWH and cervical abnormalities despite antiretroviral therapy (ART) is required to inform regionally appropriate cervical cancer…